Table 2.
Toxicity | Cohort 1 (n = 3), Grade ≤2/≥3 | Cohort 2 (n = 4), Grade ≤2/≥3 | Cohort 3 (n = 4), Grade ≤2/≥3 |
---|---|---|---|
Noncardiac chest pain | 1/0 | 0/0 | 0/0 |
Hot flashes | 3/0 | 0/0 | 0/0 |
Headache | 1/0 | 0/0 | 0/0 |
Nausea | 1/0 | 0/0 | 1/0 |
Back pain | 1/0 | 0/0 | 1/0 |
Fatigue | 1/0 | 1/0 | 0/0 |
Dyspepsia | 1/0 | 1/0 | 0/0 |
Anorexia | 1/0 | 1/0 | 0/0 |
Tumor pain | 1/0 | 0/0 | 0/0 |
Laryngeal fistula | 1/0 | 0/0 | 0/0 |
Dyspnea | 0/0 | 1/0 | 0/0 |
Anxiety | 0/0 | 1/0 | 0/0 |
Weight loss | 0/0 | 1/0 | 0/0 |
Abdominal pain | 0/0 | 2/0 | 0/0 |
Diarrhea | 0/0 | 1/0 | 2/0 |
Aspartate aminotransferase increased | 0/0 | 1/0 | 1/0 |
Generalized muscle weakness | 0/0 | 0/0 | 1/0 |
Neoplasms benign | 0/0 | 0/0 | 1/0 |
Constipation | 0/0 | 0/0 | 1/0 |
Fever | 0/0 | 0/0 | 1/0 |
Dizziness | 0/0 | 0/0 | 1/0 |
Urinary urgency | 0/0 | 0/0 | 1/0 |